Hormonal Contraceptives Market Research Report by Hormone Type (Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens), by Method Type (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, and Oral Contraceptives), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Hormonal Contraceptives Market is expected to grow from USD 14,258.67 Million in 2020 to USD 18,843.84 Million by the end of 2025.
2. The Global Hormonal Contraceptives Market is expected to grow from EUR 12,502.27 Million in 2020 to EUR 16,522.63 Million by the end of 2025.
3. The Global Hormonal Contraceptives Market is expected to grow from GBP 11,114.54 Million in 2020 to GBP 14,688.66 Million by the end of 2025.
4. The Global Hormonal Contraceptives Market is expected to grow from JPY 1,521,761.40 Million in 2020 to JPY 2,011,115.23 Million by the end of 2025.
5. The Global Hormonal Contraceptives Market is expected to grow from AUD 20,705.48 Million in 2020 to AUD 27,363.76 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Hormonal Contraceptives to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Hormone Type, the Hormonal Contraceptives Market studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
Based on Method Type, the Hormonal Contraceptives Market studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
Based on End-user, the Hormonal Contraceptives Market studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
Based on Geography, the Hormonal Contraceptives Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hormonal Contraceptives Market including AbbVie Inc., Afaxys, Inc, Agile Therapeutics, Amgen Inc., Ansell Ltd, Apothecus Pharmaceutical Corporation, Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Covetrus, Inc., Glenmark Pharmaceuticals, HLL Lifecare Limited, Johnson & Johnson Services, Inc, Lupin Pharmaceuticals, Inc., Mayer Laboratories, Inc, Merck & Co. Inc., Mylan N.V, Novartis International AG, Pfizer, Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Vardhman Life Care Pvt. Ltd., and Warner Chilcott Company.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Hormonal Contraceptives Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hormonal Contraceptives Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormonal Contraceptives Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormonal Contraceptives Market?
4. What is the competitive strategic window for opportunities in the Global Hormonal Contraceptives Market?
5. What are the technology trends and regulatory frameworks in the Global Hormonal Contraceptives Market?
6. What are the modes and strategic moves considered suitable for entering the Global Hormonal Contraceptives Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Hormonal Contraceptives Market is expected to grow from USD 14,258.67 Million in 2020 to USD 18,843.84 Million by the end of 2025.
2. The Global Hormonal Contraceptives Market is expected to grow from EUR 12,502.27 Million in 2020 to EUR 16,522.63 Million by the end of 2025.
3. The Global Hormonal Contraceptives Market is expected to grow from GBP 11,114.54 Million in 2020 to GBP 14,688.66 Million by the end of 2025.
4. The Global Hormonal Contraceptives Market is expected to grow from JPY 1,521,761.40 Million in 2020 to JPY 2,011,115.23 Million by the end of 2025.
5. The Global Hormonal Contraceptives Market is expected to grow from AUD 20,705.48 Million in 2020 to AUD 27,363.76 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Hormonal Contraceptives to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Hormone Type, the Hormonal Contraceptives Market studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
Based on Method Type, the Hormonal Contraceptives Market studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
Based on End-user, the Hormonal Contraceptives Market studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
Based on Geography, the Hormonal Contraceptives Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hormonal Contraceptives Market including AbbVie Inc., Afaxys, Inc, Agile Therapeutics, Amgen Inc., Ansell Ltd, Apothecus Pharmaceutical Corporation, Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Covetrus, Inc., Glenmark Pharmaceuticals, HLL Lifecare Limited, Johnson & Johnson Services, Inc, Lupin Pharmaceuticals, Inc., Mayer Laboratories, Inc, Merck & Co. Inc., Mylan N.V, Novartis International AG, Pfizer, Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Vardhman Life Care Pvt. Ltd., and Warner Chilcott Company.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Hormonal Contraceptives Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hormonal Contraceptives Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormonal Contraceptives Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormonal Contraceptives Market?
4. What is the competitive strategic window for opportunities in the Global Hormonal Contraceptives Market?
5. What are the technology trends and regulatory frameworks in the Global Hormonal Contraceptives Market?
6. What are the modes and strategic moves considered suitable for entering the Global Hormonal Contraceptives Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Hormone Type Outlook
3.4. End-user Outlook
3.5. Method Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about the benefits and use of contraceptives
5.1.1.2. Government initiatives to promote the use of contraceptives
5.1.1.3. Need for oral contraceptives as a preferred method to avoid unplanned pregnancy
5.1.2. Restraints
5.1.2.1. Growing use of biologics instead of traditional chemical drugs
5.1.3. Opportunities
5.1.3.1. Increasing demand for a healthy life in emerging economies
5.1.3.2. Technological advancements in contraceptive methods
5.1.4. Challenges
5.1.4.1. Limited social acceptance
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY HORMONE TYPE
6.1. Introduction
6.2. Androgens
6.3. Antiandrogens
6.4. Estrogens
6.5. Gonadotropins
6.6. Progestogens
7. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY METHOD TYPE
7.1. Introduction
7.2. Combined Oral Contraceptives
7.3. Implanted Contraceptives
7.4. Injected Contraceptives
7.5. Intrauterine
7.6. Oral Contraceptives
7.7. Transdermal Patch
7.8. Vaginal Ring
8. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY END-USER
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Gynecology Centers
8.4. Homecare
8.5. Hospitals & Clinics
9. AMERICAS HORMONAL CONTRACEPTIVES MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AbbVie Inc.
13.2. Afaxys, Inc
13.3. Agile Therapeutics
13.4. Amgen Inc.
13.5. Ansell Ltd
13.6. Apothecus Pharmaceutical Corporation
13.7. Bayer AG
13.8. BioSante Pharmaceuticals Inc.
13.9. Boehringer Ingelheim GmbH
13.10. Church & Dwight, Co., Inc.
13.11. Cipla Limited
13.12. Covetrus, Inc.
13.13. Glenmark Pharmaceuticals
13.14. HLL Lifecare Limited
13.15. Johnson & Johnson Services, Inc
13.16. Lupin Pharmaceuticals, Inc.
13.17. Mayer Laboratories, Inc
13.18. Merck & Co. Inc.
13.19. Mylan N.V
13.20. Novartis International AG
13.21. Pfizer, Inc.
13.22. Piramal Healthcare Limited
13.23. Reckitt Benckiser Group PLC
13.24. Sun Pharmaceutical Industries Ltd.
13.25. Teva Pharmaceutical Industries
13.26. Vardhman Life Care Pvt. Ltd.
13.27. Warner Chilcott Company
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Hormone Type Outlook
3.4. End-user Outlook
3.5. Method Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing awareness about the benefits and use of contraceptives
5.1.1.2. Government initiatives to promote the use of contraceptives
5.1.1.3. Need for oral contraceptives as a preferred method to avoid unplanned pregnancy
5.1.2. Restraints
5.1.2.1. Growing use of biologics instead of traditional chemical drugs
5.1.3. Opportunities
5.1.3.1. Increasing demand for a healthy life in emerging economies
5.1.3.2. Technological advancements in contraceptive methods
5.1.4. Challenges
5.1.4.1. Limited social acceptance
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY HORMONE TYPE
6.1. Introduction
6.2. Androgens
6.3. Antiandrogens
6.4. Estrogens
6.5. Gonadotropins
6.6. Progestogens
7. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY METHOD TYPE
7.1. Introduction
7.2. Combined Oral Contraceptives
7.3. Implanted Contraceptives
7.4. Injected Contraceptives
7.5. Intrauterine
7.6. Oral Contraceptives
7.7. Transdermal Patch
7.8. Vaginal Ring
8. GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY END-USER
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Gynecology Centers
8.4. Homecare
8.5. Hospitals & Clinics
9. AMERICAS HORMONAL CONTRACEPTIVES MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AbbVie Inc.
13.2. Afaxys, Inc
13.3. Agile Therapeutics
13.4. Amgen Inc.
13.5. Ansell Ltd
13.6. Apothecus Pharmaceutical Corporation
13.7. Bayer AG
13.8. BioSante Pharmaceuticals Inc.
13.9. Boehringer Ingelheim GmbH
13.10. Church & Dwight, Co., Inc.
13.11. Cipla Limited
13.12. Covetrus, Inc.
13.13. Glenmark Pharmaceuticals
13.14. HLL Lifecare Limited
13.15. Johnson & Johnson Services, Inc
13.16. Lupin Pharmaceuticals, Inc.
13.17. Mayer Laboratories, Inc
13.18. Merck & Co. Inc.
13.19. Mylan N.V
13.20. Novartis International AG
13.21. Pfizer, Inc.
13.22. Piramal Healthcare Limited
13.23. Reckitt Benckiser Group PLC
13.24. Sun Pharmaceutical Industries Ltd.
13.25. Teva Pharmaceutical Industries
13.26. Vardhman Life Care Pvt. Ltd.
13.27. Warner Chilcott Company
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SCORES
TABLE 111. GLOBAL HORMONAL CONTRACEPTIVES MARKET: BUSINESS STRATEGY
TABLE 112. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PRODUCT SATISFACTION
TABLE 113. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RANKING
TABLE 114. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MERGER & ACQUISITION
TABLE 115. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 116. GLOBAL HORMONAL CONTRACEPTIVES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 117. GLOBAL HORMONAL CONTRACEPTIVES MARKET: INVESTMENT & FUNDING
TABLE 118. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 119. GLOBAL HORMONAL CONTRACEPTIVES MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SCORES
TABLE 111. GLOBAL HORMONAL CONTRACEPTIVES MARKET: BUSINESS STRATEGY
TABLE 112. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PRODUCT SATISFACTION
TABLE 113. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RANKING
TABLE 114. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MERGER & ACQUISITION
TABLE 115. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 116. GLOBAL HORMONAL CONTRACEPTIVES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 117. GLOBAL HORMONAL CONTRACEPTIVES MARKET: INVESTMENT & FUNDING
TABLE 118. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 119. GLOBAL HORMONAL CONTRACEPTIVES MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2025
FIGURE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2025
FIGURE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 33. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2025
FIGURE 35. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 39. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 75. GLOBAL HORMONAL CONTRACEPTIVES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY TYPE
FIGURE 1. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2025
FIGURE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2025
FIGURE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 33. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2025
FIGURE 35. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 39. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 40. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 42. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 62. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
FIGURE 75. GLOBAL HORMONAL CONTRACEPTIVES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY TYPE
